SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000891618-00-002867
Filing Date
2000-05-15
Accepted
2000-05-15 00:00:00
Documents
2
Period of Report
2000-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q 10-Q 62477
2 EXHIBIT 27.1 EX-27.1 2286
  Complete submission text file 0000891618-00-002867.txt   66254
Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22570 | Film No.: 634681
SIC: 2833 Medicinal Chemicals & Botanical Products